AstraZeneca’s Post

AstraZeneca’s focus on addressing the complexity of CVRM diseases is both timely and critical. With the prevalence of these interconnected conditions rising globally, an integrated approach to care is essential for improving patient outcomes. Mina Makar's insights on combination therapies underscore the importance of advancing science to tackle the challenges of managing multiple conditions simultaneously. Collaboration and innovation in this space have the potential to transform how CVRM diseases are treated, making a meaningful difference for millions worldwide. Kudos to AstraZeneca for driving the conversation on holistic care and therapeutic innovation! #CVRM #IntegratedCare #TherapeuticInnovation #AstraZeneca #HealthcareAdvancement

📢 #Review Sharing 📚 Uric acid in atherosclerosis and cardiovascular diseases: innocent bystander or ruthless killer? ✒ Cimmino G, Natale F, Franzese R, Morello M, Titolo G, Mollo N, et al 💡 The purpose of this review is to briefly describe the main clinical and epidemiological evidence supporting the role of hyperuricemia as a possible emerging cardiovascular risk factor and to analyze the potential pathophysiological mechanisms through which elevated UA levels may exert a detrimental effect on the cardiovascular system. 🔎 Full article: https://lnkd.in/emB_y4p8 🔎 PDF: https://lnkd.in/erwA-2ZE

Apostar( muito)na prevenção? essencial! custos? Lancet group- fast facts: ”The burden of non-communicable diseases (NCDs) cannot be understated. Chronic diseases, including cardiovascular diseases, cancers, chronic respiratory diseases, and diabetes, are responsible for 41 million deaths, almost three-quarters of all deaths globally; The estimated global cost of all preventable NCDs and mental health conditions for 2020–30 is US$301·8 billion. Of that, type 2 diabetes accounts for 2% of preventable cases but 9% of costs; In the USA, on average, people with diagnosed diabetes have medical expenditures that are more than double what would be expected for people without diabetes; The problem is clear. NCDs are growing and the associated costs are enormous. It is essential that a unified approach between governments, international organisations, and pharmaceutical companies is adopted if the burdens and costs of NCDs are to be mitigated.” https://lnkd.in/d9EjRWix

A comprehensive analysis involving over 862,000 individuals reveals that people with gout face a 58% increased risk of developing cardiovascular diseases, spanning 12 different conditions such as heart failure and valve diseases. ⁠ ⁠ This study sheds light on the broader impact of gout-related organ damage, emphasizing the importance of targeted interventions and heightened awareness. ⁠ ⁠ Explore the full research findings – visit the link in bio. #GoutResearch #CardiovascularHealth #MedicalInsights

Most people with heart disease consume excessive amounts of sodium, study finds ✔ A new study found that people with cardiovascular disease consumed double the amount of sodium per day than recommended. Of people with heart disease, 89% consumed more than the recommended allowance of 1,500 mg per day. ✔Current recommendations for the maximum amount of sodium per day for people without heart disease is 2,300 mg, about the equivalent of a teaspoon of table salt. ✔While it is difficult to know how much sodium one is actually consuming, there are various strategies for avoiding excess sodium. #excessivesodium #aayucart #medicalhealth #heartdisease #onlinemedicine #medicinecart

Rare Disease Day 2024 prompts us to reflect on the challenges faced by individuals affected by rare diseases worldwide. Although these conditions are individually rare, they collectively impact a staggering 300 million people, as per recent estimates. Our platform, the Pulmonary Hypertension Knowledge Sharing Platform , is specifically dedicated to the rare forms of pulmonary hypertension, notably #pulmonaryarterialhypertension (#PAH) and #chronicthromboembolicpulmonaryhypertension (#CTEPH). Over the past three decades, significant strides have been made in comprehending and managing pulmonary hypertension. From groundbreaking therapies to specialized centers and clinical guidelines, the landscape of care has undergone a remarkable transformation. Nonetheless, life with pulmonary hypertension remains arduous for patients, their families, and caregivers, posing physical, practical, psychological, and social challenges. Our platform aims to empower patients through education. Discover more about us at ph-ksp.com. HTaPFrance Stichting Pulmonale Hypertensie / PH Association the Netherlands PH Belgium - Pulmonale Hypertensie vzw AIPI Italian Pulmonary Hypertension Association Pulmoner Hipertansiyon ve Skleroderma Hasta Dernegi Hellenic Community for Pulmonary Hypertension Pulmonale Hypertonie E.V. Ieva Plume PHA Polska PHA Japan

A new study on fish oil supplements suggests they may increase the risk of first-time heart disease and stroke but slow the progression of existing cardiovascular disease. The researchers stress the need for further investigation into the precise mechanisms involved. However, the study is purely observational and lacks conclusive evidence on the protective effects of fish oil supplements.</div><div class="read-more"><a href="https://accionvegana.org/accio/0ITbvNmLulGZltmbpxmL3d3d6MHc0/" class="more-link">Continue reading</a>https://lnkd.in/gYwFM34r

https://lnkd.in/ef5-HmWB https://t.co/IEOyj2wCfh Inter-relationships between cardiovascular, renal and metabolic diseases: Underlying evidence and implications for integrated interdisciplinary care and management

PLTs dysfunction is increased during increased mortality and morbidity processes, in vivo however. During COVID-19 pandemic attacks what were the main cause(s) of PLTs dysfunction, certain cause-effects was (were) not elucidated completely. In this paper is focused on different kinds of acute and chronically diseases i.e. Cardiovascular and CADs and focused on PLATELETs dysfunction after subjects were infected with COVID-19 variants.

Unraveling the Mystery of Coronary Vasospasm in Substance Users Coronary vasospasm represents a unique and intriguing challenge within the spectrum of cardiovascular diseases, characterised by the sudden constriction of coronary arteries that can lead to diminished blood flow to the heart muscle. This phenomenon can cause significant heart discomfort, known as angina, and in more severe scenarios, myocardial infarction or arrhythmias. Understanding the nuances&#8230; Read More: https://lnkd.in/eWUV9Q-u